Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126002611 | 12600261 | 1 | I | 201505 | 20160712 | 20160727 | 20160727 | EXP | US-JNJFOC-20160720723 | JANSSEN | 68.00 | YR | E | M | Y | 78.00000 | KG | 20160727 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126002611 | 12600261 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | QD | ||||
126002611 | 12600261 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 22406 | 15 | MG | TABLET | QD | ||||
126002611 | 12600261 | 3 | SS | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
126002611 | 12600261 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | ON DAYS 1-21 | 0 | 15 | MG | UNSPECIFIED | QD | ||||||
126002611 | 12600261 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 30 | MG | UNSPECIFIED | ||||||||
126002611 | 12600261 | 6 | C | MIDODRINE | MIDODRINE | 1 | Oral | 0 | 2.5 | MG | UNSPECIFIED | BID | |||||||
126002611 | 12600261 | 7 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 40 | MG | UNSPECIFIED | QD | |||||||
126002611 | 12600261 | 8 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | UNSPECIFIED | QD | |||||||
126002611 | 12600261 | 9 | C | ZYPREXA | OLANZAPINE | 1 | Oral | 0 | 2.5 | MG | UNSPECIFIED | ||||||||
126002611 | 12600261 | 10 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | UNSPECIFIED | TID | |||||||
126002611 | 12600261 | 11 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | UNSPECIFIED | QD | |||||||
126002611 | 12600261 | 12 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 0 | 80 | MG | UNSPECIFIED | QD | |||||||
126002611 | 12600261 | 13 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | UNSPECIFIED | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126002611 | 12600261 | 1 | Deep vein thrombosis |
126002611 | 12600261 | 2 | Deep vein thrombosis |
126002611 | 12600261 | 3 | Hypertension |
126002611 | 12600261 | 4 | Plasma cell myeloma |
126002611 | 12600261 | 5 | Plasma cell myeloma |
126002611 | 12600261 | 9 | Agitation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126002611 | 12600261 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126002611 | 12600261 | Acute kidney injury | |
126002611 | 12600261 | Anxiety | |
126002611 | 12600261 | Aortic dilatation | |
126002611 | 12600261 | Arthralgia | |
126002611 | 12600261 | Atrial fibrillation | |
126002611 | 12600261 | Blood thyroid stimulating hormone increased | |
126002611 | 12600261 | Hyperlipidaemia | |
126002611 | 12600261 | Hypoglycaemia | |
126002611 | 12600261 | Ileus | |
126002611 | 12600261 | Melaena | |
126002611 | 12600261 | Mitral valve incompetence | |
126002611 | 12600261 | Orthostatic hypotension | |
126002611 | 12600261 | Pancytopenia | |
126002611 | 12600261 | Pulmonary hypertension | |
126002611 | 12600261 | Tricuspid valve incompetence | |
126002611 | 12600261 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126002611 | 12600261 | 1 | 201607 | 0 | ||
126002611 | 12600261 | 2 | 20160712 | 0 | ||
126002611 | 12600261 | 4 | 20160617 | 0 | ||
126002611 | 12600261 | 5 | 20160617 | 0 |